Learn About Myocardial Infarction and Acute Coronary Syndrome

OSUWexnerbloglogo2014 Learn About Myocardial Infarction and Acute Coronary Syndrome on webcast. The latter half of the 1970s saw huge leaps in MI care with use of the fibrinolytics to open blocked arteries, the first cardiac angioplasty and stent placement. Since then our knowledge has continued to grow by leaps and bounds. To teach us about the epidemiology, spectrum of disease and treatment of myocardial infarctions and acute coronary syndromes is one of Ohio State University’s Interventional Cardiologists. We’re pleased to introduce Associate Professor of Cardiovascular Medicine Dr Scott Lilly.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: understand the pathophysiology and diagnosis of acute coronary syndromes; and identify therapies that reduce mortality in acute coronary syndromes.

You’ll also learn about the following:

  • Antiplatelet drug selection
  • Lytics
  • ACS in Women
  • Silent MIs
  • Cardiac Rehab
  • Prevention

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn about Heart Disease in Women

OSUWexnerbloglogo2014 Learn about Heart Disease in Women on our latest webcast. Heart disease is different between men and women, the symptoms can be different and even the types of heart diseases can be different.  Joining our moderator, Dr. Jim Allen, in the studio to update us on heart disease in women is Associate Professor of Internal Medicine and the Director of the Women’s Cardiovascular Health Program at the Ohio State University, Dr. Laxmi Mehta.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the risk factors and clinical presentation of cardiovascular disease in women; and REVIEW causes of myocardial infarction in women without obstructive coronary artery disease.

You’ll also learn about the following:

  • Gender differences in cardiovascular disease symptoms and outcomes
  • Gender differences in heart disease epidemiology
  • Gender differences in cardiovascular stress tests
  • Statins and aspirin in women
  • Birth control pills and cardiovascular disease

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.